| 1. | mrwhtwabbit | |
| 2. | emielnl | |
| 3. | codcoleu1ou0m4sl | |
| 4. | ree222 | |
| 5. | dimespent |
Top Board Researchers
These are the top researchers based on quality of posts as voted by board members. Typically they know their stuff and are a great
way to catch up on what the company is all about.
HOW DO I BECOME ONE?
Just do great research! As other members approve of your posts, you earn points that move you up the ranks.| 1. | emielnl 03/07/2018 Reports new clinical data demonstrate high vaccine efficacy of Fluarix Tetra in children 6-35 months of age |
| 2. | dimespent 04/03/2018 US FDA accepts Biologics license application for moxetumomab pasudotox in hairy cell leukemia |
| 3. | ree222 03/09/2018 Announces positive EU Approval for labelling update to Relvar Ellipta in patients with Asthma |
| 4. | mrwhtwabbit 02/07/2018 Going for the throat |
| 5. | codcoleu1ou0m4sl 01/25/2018 Johnson & Johnson has pulled out of the race to buy Pfizer's consumer health business, leaving GlaxoSmithKli… |
| 6. | mrwhtwabbit 07/25/2018 Reports negative outcome of the FDA Advisory Committee on mepolizumab for the treatment of COPD patients on m… |
| 7. | mrwhtwabbit 02/15/2018 Receives European approval for expanded indication for Fluarix Tetra (Influenza Vaccine) for ages six months … |
| 8. | emielnl 02/07/2018 GlaxoSmithKlines Bexsero receives Breakthrough Therapy Designation from FDA |
| 9. | mrwhtwabbit 02/07/2018 Good beat. |
| 10. | emielnl 03/23/2018 Shingrix approved in Europe and Japan for the prevention of shingles in adults aged 50 and over |
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW
GlaxoSmithKline PLC
- GSK
- Public Stock Message Board
Filtering by:
-
To use your chart in a post, click the
icon above the chart. From there you can get the chart link or download the image.